» Articles » PMID: 26579129

Redirection of Epithelial Immune Responses by Short-Chain Fatty Acids Through Inhibition of Histone Deacetylases

Overview
Journal Front Immunol
Date 2015 Nov 19
PMID 26579129
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Short-chain fatty acids (SCFAs) are products of microbial fermentation that are important for intestinal epithelial health. Here, we describe that SCFAs have rapid and reversible effects on toll-like receptor (TLR) responses in epithelial cells. Incubation of HEK293 or HeLa epithelial cells with the SCFAs butyrate or propionate at physiological concentrations enhanced NF-κB activation induced by TLR5, TLR2/1, TLR4, and TLR9 agonists. NF-κB activation in response to tumor necrosis factor α (TNFα) was also increased by SCFAs. Comparative transcript analysis of HT-29 colon epithelial cells revealed that SCFAs enhanced TLR5-induced transcription of TNFα but dampened or even abolished the TLR5-mediated induction of IL-8 and monocyte chemotactic protein 1. SCFAs are known inhibitors of histone deacetylases (HDACs). Butyrate or propionate caused a rapid increase in histone acetylation in epithelial cells, similar to the small molecule HDAC inhibitor trichostatin A (TSA). TSA also mimicked the effects of SCFAs on TLR-NF-κB responses. This study shows that bacterial SCFAs rapidly alter the epigenetic state of host cells resulting in redirection of the innate immune response and selective reprograming of cytokine/chemokine expression.

Citing Articles

Dual independent mechanisms underlying gut epithelial remodeling upon sugar substitute consumption.

Seo D, Hong K, Lee J, Lee J, Jeong Y FASEB J. 2025; 39(3):e70374.

PMID: 39902882 PMC: 11891951. DOI: 10.1096/fj.202402105RR.


Should we consider microbiota-based interventions as a novel therapeutic strategy for schizophrenia? A systematic review and meta-analysis.

Hassib L, Kanashiro A, Pedrazzi J, Vercesi B, Higa S, Arruda I Brain Behav Immun Health. 2025; 43():100923.

PMID: 39839986 PMC: 11745983. DOI: 10.1016/j.bbih.2024.100923.


Causal Relationships Between Gut Microbiota, Metabolites, and Diabetic Nephropathy: Insights from a Two-Sample Mendelian Randomization Analysis.

Song X, Cui J, Li S, Huang B Int J Nephrol Renovasc Dis. 2024; 17:319-332.

PMID: 39679125 PMC: 11645948. DOI: 10.2147/IJNRD.S489074.


Histone Deacetylases (HDACs) Roles in Inflammation-mediated Diseases; Current Knowledge.

Jasim S, Altalbawy F, Abohassan M, Oghenemaro E, Kumar Bishoyi A, Singh R Cell Biochem Biophys. 2024; .

PMID: 39419931 DOI: 10.1007/s12013-024-01587-0.


Fatty acids and epigenetics in health and diseases.

Chung M, Kim B Food Sci Biotechnol. 2024; 33(14):3153-3166.

PMID: 39328231 PMC: 11422405. DOI: 10.1007/s10068-024-01664-3.


References
1.
Maslowski K, Vieira A, Ng A, Kranich J, Sierro F, Yu D . Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009; 461(7268):1282-6. PMC: 3256734. DOI: 10.1038/nature08530. View

2.
Falkenberg K, Johnstone R . Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov. 2014; 13(9):673-91. DOI: 10.1038/nrd4360. View

3.
Heerdt B, Houston M, Augenlicht L . Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res. 1994; 54(12):3288-93. View

4.
Van Lint C, Emiliani S, Verdin E . The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 1996; 5(4-5):245-53. PMC: 6138027. View

5.
Hinnebusch B, Meng S, Wu J, Archer S, Hodin R . The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr. 2002; 132(5):1012-7. DOI: 10.1093/jn/132.5.1012. View